Bodnar A G, Rachubinski R A
Department of Biochemistry, McMaster University, Hamilton, Ont., Canada.
Biochem Cell Biol. 1991 Aug;69(8):499-508. doi: 10.1139/o91-074.
We have characterized the integral membrane polypeptides of liver peroxisomes from untreated rats and rats treated with clofibrate, a peroxisome proliferator. Membranes, prepared by treatment of purified peroxisomes with sodium carbonate, were used to raise an antiserum in rabbits. Immunoblot analysis demonstrated the reaction of this antiserum with six peroxisomal integral membrane polypeptides (molecular masses, 140, 69, 50, 36, 22, and 15 kDa). Treatment of rats with the hypolipidemic drug clofibrate caused a 4- to 10-fold induction in the 69-kDa integral membrane polypeptide, while the other integral membrane polypeptides remained unchanged or varied to a lesser extent. The anti-peroxisomal membrane serum reacted with two integral membrane polypeptides of the endoplasmic reticulum which co-migrated with the 50- and 36-kDa integral membrane polypeptides of the peroxisome. Biochemical and immunoblot analyses indicated that these integral membrane polypeptides were co-localized to peroxisomes and endoplasmic reticulum. Immunoprecipitation of in vitro translation products of RNA isolated from free and membrane-bound polysomes indicated that the 22-, 36-, and 69-kDa integral membrane polypeptides were synthesized on free polysomes, while the 50-kDa integral membrane polypeptide was predominantly synthesized on membrane-bound polysomes. The predominant synthesis of the 50-kDa integral membrane polypeptide on membrane-bound polysomes raises interesting possibilities concerning its biosynthesis.
我们已对未处理大鼠以及用氯贝丁酯(一种过氧化物酶体增殖剂)处理过的大鼠肝脏过氧化物酶体的整合膜多肽进行了表征。通过用碳酸钠处理纯化的过氧化物酶体制备的膜,用于在兔中产生抗血清。免疫印迹分析表明该抗血清与六种过氧化物酶体整合膜多肽(分子量分别为140、69、50、36、22和15 kDa)发生反应。用降血脂药物氯贝丁酯处理大鼠导致69 kDa整合膜多肽诱导4至10倍,而其他整合膜多肽保持不变或变化程度较小。抗过氧化物酶体膜血清与内质网的两种整合膜多肽发生反应,这两种多肽与过氧化物酶体的50 kDa和36 kDa整合膜多肽共迁移。生化和免疫印迹分析表明,这些整合膜多肽共定位于过氧化物酶体和内质网。对从游离和膜结合多核糖体分离的RNA的体外翻译产物进行免疫沉淀表明,22 kDa、36 kDa和69 kDa整合膜多肽在游离多核糖体上合成,而50 kDa整合膜多肽主要在膜结合多核糖体上合成。50 kDa整合膜多肽在膜结合多核糖体上的主要合成提出了关于其生物合成的有趣可能性。